Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

https://clinicaltrials.gov/ct2/show/NCT02324335?term=brilacidin&rank=1
https://clinicaltrials.gov/ct2/show/NCT02508389?term=galera&rank=8

Maybe I shouldn't have been surprised by the number of consistent elements between the inclusion and exclusion criteria of the two trials. Would that be simply because both were designed to track standard treatment practices...

OR

Would Galera have taken the Brilacidin trial elements into consideration when designing their own trial for some reason? They had been made public 7 months earlier.
Brilacidin: First Posted : December 24, 2014
GC4419: First Posted : July 24, 2015


_______________________________________________
"Brilacidin 3 mg/mL in Water for Injection"

Any reason not to test a second level of concentration?
What does "injection" mean in this context?